Gelonghui, April 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that the time period for the company's actual share repurchase was from December 8, 2023 to March 29, 2024. The cumulative number of shares repurchased through centralized bidding transactions through the repurchase special securities account was 15,500,000 shares, accounting for 1.1072% of the company's total share capital. The maximum transaction price of the repurchase was 6.78 yuan/share, and the minimum transaction price was 5.18 yuan/share, and the total transaction amount was about RMB 100 million (excluding transaction fees).
仁和药业(000650.SZ)：回购完成 已累计回购1.107%股份
Renhe Pharmaceutical (000650.SZ): The repurchase has completed a cumulative total of 1.107% shares have been repurchased
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.